Cargando…
Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm
BACKGROUND: Four randomized controlled trials have demonstrated the short-term efficacy and safety of transoral esophagogastric fundoplication (TF) performed with the EsophyX(®) device in eliminating troublesome gastroesophageal reflux disease (GERD) symptoms in well-selected patient populations. Th...
Autores principales: | Trad, Karim S., Fox, Mark A., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Barnes, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443856/ https://www.ncbi.nlm.nih.gov/pubmed/27655380 http://dx.doi.org/10.1007/s00464-016-5252-8 |
Ejemplares similares
-
Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial
por: Trad, Karim S., et al.
Publicado: (2015) -
The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective
por: Trad, Karim S., et al.
Publicado: (2018) -
Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study
por: Trad, Karim Sami, et al.
Publicado: (2014) -
Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms
por: Trad, Karim S., et al.
Publicado: (2011) -
Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals
por: Janu, Peter, et al.
Publicado: (2019)